Home
NGHIÊN CỨU LÂM SÀNG
Issue: Số 102, 2022
Article
Nguyễn Ngọc Linh: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Nguyễn Quỳnh Hoa: Khoa Dược, Bệnh viện Bạch Mai;
Nguyễn Thị Hải Yến: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Lê Thị Mến: Bộ môn Tim mạch - Trường Đại học Y Hà Nội;
Nguyễn Ngọc Quang: Bộ môn Tim mạch - Trường Đại học Y Hà Nội;
Published: November 1, 2022
Views: 164
References
1.
1. Reduce the use of generic brand-name drugs to save costs. Posted on 20/07/2020. Login date 15/5/2022 http://baokiemtoannhanuoc.vn/ban-doc-quan-tam/giam-su-dung-thuoc-biet-duoc-goc-de-tiet-kiem- chi-phi-145175.
2.
2. Ministry of Health; Circular 15/2019/TT-BT Regulations on bidding for drugs at public health facilities 2019.
3.
3. Ministry of Health; Circular 40/2014/TT-BYT Promulgating and guiding the implementation of the list of modern drugs under the payment scope of the health insurance fund 2014;
4.
4. Ministry of Health; Circular 30/2018/TT-BYT promulgating the list and payment rates and conditions for pharmaceutical chemicals, biological products, radioactive drugs and markers within the scope of benefits of health insurance participants 2018;
5.
5. Ha Thi Mai Hanh. Analysis of the current situation of original brand name drugs won the national bid in 2019. Master thesis in Pharmacology. University of Pharmacy; 2021;
6.
6. Cameron A., Mantel-Teeuwisse A. K., Leufkens H. G., Laing R. O. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. Jul-Aug 2012;15(5):664-73. doi:10.1016/j.jval.2012.04.004
7.
7. Ministry of Health; Circular 15/2020/TT-BYT Promulgating the list of drugs for bidding, the list of drugs for concentrated bidding, and the list of drugs eligible for price negotiation in 2020.